The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

1–3 In the present study we have reinvestigated 4 cases of the early series reported from St. Louis 2 for the presence of antinuclear antibodies. We have also sought such antibodies in 13 ...

[41] † Correlation of antinuclear antibodies with unfavorable disease course. ‡ 21 additional healthy controls tested negative. § Antitotal IgG as secondary antibody. ¶ Anti-IgG1, IgG2 and ...

ImmunoPrecise Antibodies (IPA) announced a strategic collaboration with Ribopro. This collaboration seeks to revolutionize the discovery and development of therapeutic antibodies by integrating ...

Background: Although antinuclear antibody (ANA) is frequently observed in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), its clinical significance in children remains ...

The Antinuclear Antibody Test Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape. It ...

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology ...

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Only adult patients with autoantibody reactivity greater than 1/80 for the classical markers, such as anti-smooth muscle antibodies (ASMAs), anti-nuclear antibodies (ANAs), and anti-liver/kidney ...